Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001017592 | SCV001178691 | likely benign | Hereditary cancer-predisposing syndrome | 2018-03-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV001017592 | SCV001357868 | likely benign | Hereditary cancer-predisposing syndrome | 2019-05-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002549456 | SCV003330082 | likely benign | Juvenile polyposis syndrome | 2023-08-06 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV002549456 | SCV005405873 | benign | Juvenile polyposis syndrome | 2024-08-05 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |